Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia. (Record no. 24305096)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02161 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517001051.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201608s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1559-1182 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s12035-014-8936-x |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Farré, Daniel |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160810 |
| 245 00 - TITLE STATEMENT | |
| Title | Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Molecular neurobiology |
| Date of publication, distribution, etc. | Dec 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1408-1420 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Caudate Nucleus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Corpus Striatum |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dimerization |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dominance, Cerebral |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dopamine |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dopamine Agonists |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dyskinesia, Drug-Induced |
| General subdivision | etiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression Regulation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Levodopa |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Macaca fascicularis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oxidopamine |
| General subdivision | toxicity |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Parkinsonian Disorders |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Putamen |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radioligand Assay |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats, Wistar |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Dopamine D1 |
| General subdivision | agonists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Dopamine D3 |
| General subdivision | biosynthesis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Muñoz, Ana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moreno, Estefanía |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reyes-Resina, Irene |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Canet-Pons, Júlia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dopeso-Reyes, Iria G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rico, Alberto J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lluís, Carme |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mallol, Josefa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Navarro, Gemma |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Canela, Enric I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cortés, Antonio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Labandeira-García, José L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Casadó, Vicent |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lanciego, José L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Franco, Rafael |
| 773 0# - HOST ITEM ENTRY | |
| Title | Molecular neurobiology |
| Related parts | vol. 52 |
| -- | no. 3 |
| -- | p. 1408-1420 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s12035-014-8936-x">https://doi.org/10.1007/s12035-014-8936-x</a> |
| Public note | Available from publisher's website |
No items available.